The novel mechanism of valproate to prevent peritoneal adhesion formation
The novel mechanism of valproate to prevent peritoneal adhesion formation
复制标题
丙戊酸预防腹膜粘连形成的新机制
DOI:
10.1007/s00595-020-01979-8
复制
发表时间:
2020-04-01
期刊:
影响因子:
2.5
通讯作者:
Takai, Shinji
中科院分区:
文献类型:
--
作者:
Liu, Shuangping;Liu, Liping;Takai, Shinji
Purpose A novel pharmacological mechanism of valproate was analyzed using a hamster model of adhesion. Methods Valproate or placebo was administered just after cecal injury and adhesion severity scores and histological were analyzed. Results The adhesion severity scores in the placebo- and valproate-treated groups were 2.67 +/- 0.42 and 1.0 +/- 0.37, respectively, with a significant difference between the groups. A significant increase in mast cell numbers was observed in the placebo-treated group vs. the sham-operated group; however, the mast cell number in the adhesive lesion was significantly lower in the valproate-treated group than in the placebo-treated group. The number of cells positive for chymase, an enzyme in mast cells, in the adhesive lesion was significantly higher in the placebo-treated group, but its increase was attenuated significantly by treatment with valproate. The myeloperoxidase gene expression level in the cecum was significantly higher in the placebo-treated group than in the sham-operated group, but there was no significant difference in the myeloperoxidase gene expression level between the sham-operated and valproate-treated groups in. In an in vitro experiment, valproate inhibited purified human and hamster chymases dose-dependently. Conclusion The chymase inhibitory effect of valproate may contribute to prevent adhesion formation after abdominal injury.